North Potomac, MD, United States of America

Olga Aprelikova


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 142(Granted Patents)


Location History:

  • Helsinki, FI (1998)
  • N. Potomac, MD (US) (2000)
  • North Potomac, MD (US) (2006)

Company Filing History:


Years Active: 1998-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Olga Aprelikova

Introduction

Olga Aprelikova is a notable inventor based in North Potomac, MD (US). She has made significant contributions to the field of cancer research, particularly through her innovative patents. With a total of three patents to her name, Aprelikova's work focuses on advancements in tumor imaging and anti-tumor therapy.

Latest Patents

Aprelikova's latest patents include "FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy." This invention provides purified Flt4 receptor tyrosine kinase polypeptides and fragments, along with polynucleotides encoding these polypeptides, antibodies that specifically bind to them, and their various uses. Another significant patent is "Antibodies to Flt4, a receptor tyrosine kinase and uses thereof," which similarly offers purified Flt4 receptor tyrosine kinase polypeptides and their applications in cancer treatment.

Career Highlights

Throughout her career, Aprelikova has worked with prestigious organizations, including the Ludwig Institute for Cancer Research Limited and Helsinki University Licensing, Ltd. Her work has been instrumental in advancing the understanding and treatment of cancer.

Collaborations

Aprelikova has collaborated with notable colleagues such as Katri Pajusola and Elina Armstrong, contributing to her research and innovations in the field.

Conclusion

Olga Aprelikova's contributions to cancer research through her patents and collaborations highlight her role as a significant inventor in the medical field. Her work continues to impact the development of effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…